- Report
- November 2022
- 133 Pages
Middle East, Africa
From €3108EUR$3,450USD£2,742GBP
- Report
- November 2022
- 138 Pages
Europe
From €3108EUR$3,450USD£2,742GBP
- Report
- November 2022
- 138 Pages
Asia Pacific
From €3108EUR$3,450USD£2,742GBP
- Report
- August 2022
- 252 Pages
Global
From €4008EUR$4,450USD£3,537GBP
- Report
- August 2022
- 197 Pages
Global
From €4008EUR$4,450USD£3,537GBP
- Report
- August 2022
- 200 Pages
Global
From €4008EUR$4,450USD£3,537GBP
- Report
- December 2021
- 191 Pages
Global
From €4008EUR$4,450USD£3,537GBP
- Report
- August 2021
- 177 Pages
Global
From €4008EUR$4,450USD£3,537GBP
- Report
- March 2023
- 150 Pages
Global
From €3468EUR$3,850USD£3,060GBP
€4369EUR$4,850USD£3,855GBP
- Report
- February 2024
- 111 Pages
Global
From €4279EUR$4,750USD£3,775GBP
- Report
- February 2024
- 120 Pages
Global
From €4279EUR$4,750USD£3,775GBP
- Report
- May 2023
- 140 Pages
Global
From €4458EUR$4,949USD£3,934GBP
- Report
- December 2024
- 90 Pages
Indonesia
From €2567EUR$2,850USD£2,265GBP
- Report
- May 2024
- 124 Pages
Global
From €3558EUR$3,950USD£3,140GBP
- Report
- April 2024
- 134 Pages
Global
From €3558EUR$3,950USD£3,140GBP
- Report
- April 2024
- 135 Pages
Global
From €3558EUR$3,950USD£3,140GBP
- Report
- February 2024
- 120 Pages
Germany
From €2567EUR$2,850USD£2,265GBP
- Report
- January 2024
- 140 Pages
Global
From €3828EUR$4,250USD£3,378GBP
- Report
- September 2023
- 143 Pages
Global
From €4008EUR$4,450USD£3,537GBP
- Report
- July 2021
- 85 Pages
Global
From €4008EUR$4,450USD£3,537GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more